EXUMA Biotech logo

EXUMA Biotech

25 employees · est. 2015 · West Palm Beach, United Stat...

VS
Nectin Therapeutics logo

Nectin Therapeutics

Unlocking the power of the immune system - next-generation immunotherapy

12 employees · est. 2017 · Jerusalem, Israel

EXUMA Biotech is the older company (2015 vs 2017).

Side-by-Side Comparison

EXUMA Biotech Nectin Therapeutics
Founded
2015 older 2017
Headquarters
West Palm Beach, United States Jerusalem, Israel
Employees
25 12
Industry
Big Data, Biotechnology, Health Care Biotechnology, Life Sciences
Funding Stage
Series B Series Unknown
Total Funding
$107.00M $46.40M
Funding Rounds
4 6
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Immuno-Oncology, CAR-T, Cell Therapy, Gene Therapy, Viral Engineering, CAR-NK, Oncology, Immunotherapy Biotech, Immunotherapy, Cancer Therapy, Immune System, Therapeutic Agents, Antibodies, Resistance Mechanisms, CAR-T, CAR-NK, Targeted Therapy, Oncology, Novel Agents, Immune Cell, Tumor Targeting, Drug Development
Website
exumabio.com nectintx.com
EXUMA Biotech logo

About EXUMA Biotech

EXUMA Biotech is a clinical-stage biotechnology company committed to bringing to market cell & gene therapies for the treatment of cancer. Founded in 2015, the company has rapidly built its core technologies and a growing global presence with operations in China (Shanghai and Shenzhen), Grand Cayman...

Nectin Therapeutics logo

About Nectin Therapeutics

Nectin Therapeutics is a biotech company founded in 2017 with its headquarters in Israel. The company's focus is on unlocking the power of the immune system and developing next-generation immunotherapy agents. Nectin Therapeutics aims to address the limitations of existing immunotherapy by targeting...

We will tell you when either one moves

BounceWatch watches EXUMA Biotech and Nectin Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at EXUMA Biotech and Nectin Therapeutics — by email.

Frequently Asked Questions

EXUMA Biotech. Nectin Therapeutics — Unlocking the power of the immune system - next-generation immunotherapy . Both companies operate in related markets but may differ in funding stage, team size, and product focus.
EXUMA Biotech has raised $107.00M while Nectin Therapeutics has raised $46.40M.
EXUMA Biotech and Nectin Therapeutics operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare EXUMA Biotech with someone else

Start typing a company name or domain.

Related Comparisons

Compiled from the BounceWatch company index. We last looked at EXUMA Biotech on 11 Sep 2024, and Nectin Therapeutics on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy